Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in Oncology

Retrieve available abstracts of 42 articles:
HTML format

Single Articles

    July 2021
  1. TOKUMARU S, Koizumi T, Sekino Y, Takeuchi N, et al
    Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
    Oncology. 2021 Jul 19:1-9. doi: 10.1159/000517344.
    PubMed     Abstract available

    March 2021
  2. OKUBO K, Arigami T, Matsushita D, Tanaka T, et al
    Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
    Oncology. 2021 Mar 5:1-9. doi: 10.1159/000514572.
    PubMed     Abstract available

    January 2021
  3. JIANG DM, Sim HW, Espin-Garcia O, Chan BA, et al
    Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
    Oncology. 2021;99:49-56.
    PubMed     Abstract available

  4. NAMIKAWA T, Maeda M, Yokota K, Iwabu J, et al
    Enteral Vitamin B12 Supplementation Is Effective for Improving Anemia in Patients Who Underwent Total Gastrectomy.
    Oncology. 2021;99:225-233.
    PubMed     Abstract available

    October 2020
  5. UBUKATA Y, Ogata K, Sohda M, Yokobori T, et al
    Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Oncology. 2020 Oct 28:1-8. doi: 10.1159/000509033.
    PubMed     Abstract available

    September 2020
  6. ARIGAMI T, Matsushita D, Okubo K, Sasaki K, et al
    Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective Study.
    Oncology. 2020 Sep 9:1-9. doi: 10.1159/000509530.
    PubMed     Abstract available

  7. NAKAMURA M, Ojima T, Katsuda M, Hayata K, et al
    Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
    Oncology. 2020 Sep 2:1-5. doi: 10.1159/000509396.
    PubMed     Abstract available

    June 2020
  8. ZHOU J, Zhao Z, Zhang Y, Bao C, et al
    Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
    Oncology. 2020 Jun 10:1-6. doi: 10.1159/000505664.
    PubMed     Abstract available

    May 2020
  9. AHOPELTO K, Laitinen A, Hagstrom J, Bockelman C, et al
    Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
    Oncology. 2020 May 20:1-10. doi: 10.1159/000507350.
    PubMed     Abstract available

  10. ARIGAMI T, Matsushita D, Okubo K, Yanagita S, et al
    Response Rate and Prognostic Impact of Salvage Chemotherapy after Nivolumab in Patients with Advanced Gastric Cancer.
    Oncology. 2020 May 19:1-7. doi: 10.1159/000507219.
    PubMed     Abstract available

  11. ITO S, Masuda T, Noda M, Hu Q, et al
    Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Oncology. 2020 May 7:1-11. doi: 10.1159/000506075.
    PubMed     Abstract available

    April 2020
  12. DI PINTO F, Armentano R, Arborea G, Schena N, et al
    Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Oncology. 2020 Apr 21:1-9. doi: 10.1159/000506077.
    PubMed     Abstract available

    March 2020
  13. NAMIKAWA T, Yokota K, Yamaguchi S, Iwabu J, et al
    Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer.
    Oncology. 2020 Mar 17:1-8. doi: 10.1159/000505973.
    PubMed     Abstract available

    February 2020
  14. ARIGAMI T, Matsushita D, Okubo K, Kawasaki Y, et al
    Indication and Prognostic Significance of Conversion Surgery in Patients with Liver Metastasis from Gastric Cancer.
    Oncology. 2020 Feb 14:1-7. doi: 10.1159/000505555.
    PubMed     Abstract available

    January 2020
  15. WAKAHARA T, Kanemitsu K, Asari S, Tsuchida S, et al
    The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective Gastrectomy.
    Oncology. 2020;98:111-116.
    PubMed     Abstract available

  16. ROGERS JE, Xiao L, Trail A, Blum Murphy M, et al
    Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.
    Oncology. 2020;98:289-294.
    PubMed     Abstract available

  17. MIZRAK KAYA D, Nogueras Gonzalez GM, Harada K, Blum Murphy MA, et al
    Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma.
    Oncology. 2020;98:542-548.
    PubMed     Abstract available

  18. WUNDSAM HV, Doleschal B, Prommer R, Venhoda C, et al
    Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis.
    Oncology. 2020;98:706-713.
    PubMed     Abstract available

  19. ABDELHAKEEM A, Wang X, Rogers JE, Trail A, et al
    Outcomes of Advanced Gastroesophageal Cancer Patients with Equivocal HER2 Expression with or without ERBB2 Gene Amplification.
    Oncology. 2020;98:884-888.
    PubMed     Abstract available

    September 2019
  20. JUNG DH, Bae YJ, Kim JH, Shin YK, et al
    HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells.
    Oncology. 2019 Sep 24:1-8. doi: 10.1159/000502845.
    PubMed     Abstract available

  21. MATSUURA N, Motoori M, Fujitani K, Nishizawa Y, et al
    Correlation between Skeletal Muscle Mass and Adverse Events of Neoadjuvant Chemotherapy in Patients with Gastric Cancer.
    Oncology. 2019 Sep 11:1-6. doi: 10.1159/000502613.
    PubMed     Abstract available

  22. KOBAYASHI D, Ishigami H, Kanda M, Tanaka C, et al
    Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Oncology. 2019 Sep 5:1-5. doi: 10.1159/000502484.
    PubMed     Abstract available

    June 2019
  23. IZAWA N, Sunakawa Y, Doi A, Arai H, et al
    Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer.
    Oncology. 2019 Jun 13:1-8. doi: 10.1159/000500326.
    PubMed     Abstract available

    May 2019
  24. MICELI R, An J, Di Bartolomeo M, Morano F, et al
    Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
    Oncology. 2019 May 2:1-6. doi: 10.1159/000499628.
    PubMed     Abstract available

    January 2019
  25. WAKAHARA T, Kanemitsu K, Maeda T, Yoshikawa T, et al
    Validity of Laparoscopic Gastrectomy in the Elderly.
    Oncology. 2019;96:87-92.
    PubMed     Abstract available

  26. ROININEN N, Takala S, Haapasaari KM, Jukkola-Vuorinen A, et al
    Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Oncology. 2019;96:147-155.
    PubMed     Abstract available

    October 2018
  27. INOUE D, Sekiguchi S, Yamagata W, Maeda G, et al
    Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.
    Oncology. 2018 Oct 26:1-7. doi: 10.1159/000493427.
    PubMed     Abstract available

    August 2018
  28. PIETRANTONIO F, Barretta F, Fanotto V, Park SH, et al
    Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
    Oncology. 2018 Aug 21:1-9. doi: 10.1159/000491753.
    PubMed     Abstract available

    January 2018
  29. ELGHALI MA, Gouader A, Bouriga R, Mahjoub M, et al
    Gastric Adenocarcinomas in Central Tunisia: Evolution Specificities through Two Decades and Relation with Helicobacter pylori.
    Oncology. 2018;95:121-128.
    PubMed     Abstract available

    October 2017
  30. WAKAHARA T, Ueno N, Maeda T, Kanemitsu K, et al
    Impact of Gastric Cancer Surgery in Elderly Patients.
    Oncology. 2017 Oct 19. doi: 10.1159/000481404.
    PubMed     Abstract available

    September 2017
  31. OKI E, Okano S, Saeki H, Umemoto Y, et al
    Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
    Oncology. 2017 Sep 15. doi: 10.1159/000479231.
    PubMed     Abstract available

    May 2017
  32. KITAMURA S, Tanahashi T, Aoyagi E, Nakagawa T, et al
    Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes.
    Oncology. 2017 May 17. doi: 10.1159/000464329.
    PubMed     Abstract available

    April 2017
  33. LIM KH, Lee HY, Park SB, Song SY, et al
    Feasibility of Modified FOLFOX in Elderly Patients Aged >/=80 Years with Metastatic Gastric Cancer or Colorectal Cancer.
    Oncology. 2017 Apr 27. doi: 10.1159/000471767.
    PubMed     Abstract available

    January 2017
  34. HAAG GM, Byl A, Jager D, Berger AK, et al
    Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.
    Oncology. 2017;92:291-298.
    PubMed     Abstract available

  35. MIZRAK KAYA D, Wang X, Harada K, Blum Murphy MA, et al
    101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
    Oncology. 2017;93:243-248.
    PubMed     Abstract available

  36. BERENATO R, Morano F, Pietrantonio F, Cotsoglou C, et al
    Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
    Oncology. 2017;93:279-286.
    PubMed     Abstract available

    October 2016
  37. PASQUINI G, Vasile E, Caparello C, Vivaldi C, et al
    Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients.
    Oncology. 2016.
    PubMed     Abstract available

    August 2016
  38. KIESEWETTER B, Lukas J, Dolak W, Simonitsch-Klupp I, et al
    Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?
    Oncology. 2016.
    PubMed     Abstract available

    January 2016
  39. CHARALAMPAKIS N, Nogueras Gonzalez GM, Elimova E, Wadhwa R, et al
    The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.
    Oncology. 2016;90:239-47.
    PubMed     Abstract available

  40. SHIOZAKI H, Slack RS, Chen HC, Elimova E, et al
    Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.
    Oncology. 2016;91:55-60.
    PubMed     Abstract available

  41. CHUNG V, Frankel P, Lim D, Yeon C, et al
    Phase Ib Trial of mFOLFOX6 and Everolimus (NSC-733504) in Patients with Metastatic Gastroesophageal Adenocarcinoma.
    Oncology. 2016;90:307-12.
    PubMed     Abstract available

  42. CHOI EJ, Yoo NJ, Kim MS, An CH, et al
    Putative Tumor Suppressor Genes EGR1 and BRSK1 Are Mutated in Gastric and Colorectal Cancers.
    Oncology. 2016;91:289-294.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.